Testing KDS2010 for weight loss in overweight or obese adults
Part of Hormones & metabolism clinical trials.
This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a BMI of 30 or more, OR a BMI of 27 or more AND a weight-related health issue (like high blood pressure, high cholesterol, heart disease, or sleep apnea).
- You are willing to follow a reduced-calorie diet and exercise program for at least part of the study.
- You have not lost or gained more than 5% of your body weight in the last 12 weeks.
- You do not have diabetes, a history of major depression, or certain other medical conditions (like a recent stroke or cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This trial tests a new medication called DA-1726 for people with obesity but no other major health problems. It aims to see if the drug is safe and how it works in the body. You may qualify if your body mass index (BMI) is between 30 and 45 and your weight has been stable for 3 months.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.